CXCR4 is upregulated in malignant diseases and has a critical role in cell survival, proliferation, angiogenesis, metastasis, migration, recurrence, and resistance to chemoradiation, which lead to tumor progression and poor clinical outcome [15,16,17]. Here, CXCR4 is linked to neoplasm.